SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-23-012614
Filing Date
2023-03-20
Accepted
2023-03-20 18:43:26
Documents
1
Period of Report
2023-03-16

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 3232
  Complete submission text file 0001140361-23-012614.txt   4616
Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Issuer) CIK: 0001501989 (see all company filings)

IRS No.: 273521219 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MOURANT OZANNES CORPORATE SERVICES 94 SOLARIS AVENUE CAMANA BAY, GRAND CAYMAN E9 KY1-1108
Business Address
Peterson Amy C. (Reporting) CIK: 0001682735 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37587 | Film No.: 23747456